Korro Bio, Inc.
KRRO
$6.04
$0.7614.39%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.37M | 6.28M | 4.82M | 2.27M | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.37M | 6.28M | 4.82M | 2.27M | -- |
| Cost of Revenue | 28.94M | 31.03M | 26.95M | 26.95M | 26.95M |
| Gross Profit | -21.57M | -24.75M | -22.13M | -24.68M | -26.95M |
| SG&A Expenses | 41.16M | 42.30M | 41.84M | 41.87M | 45.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 101.87M | 104.84M | 100.30M | 94.18M | 95.76M |
| Operating Income | -94.50M | -98.55M | -95.48M | -91.91M | -95.76M |
| Income Before Tax | -88.31M | -91.26M | -87.29M | -83.44M | -87.77M |
| Income Tax Expenses | 104.00K | 95.00K | 124.00K | 141.00K | 38.00K |
| Earnings from Continuing Operations | -88.42 | -91.36 | -87.41 | -83.58 | -87.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -88.42M | -91.36M | -87.41M | -83.58M | -87.81M |
| EBIT | -94.50M | -98.55M | -95.48M | -91.91M | -95.76M |
| EBITDA | -89.62M | -93.98M | -91.41M | -88.35M | -92.47M |
| EPS Basic | -9.42 | -9.76 | -9.44 | -9.39 | -11.94 |
| Normalized Basic EPS | -5.88 | -6.09 | -5.89 | -5.86 | -7.46 |
| EPS Diluted | -9.42 | -9.76 | -9.44 | -9.39 | -11.94 |
| Normalized Diluted EPS | -5.88 | -6.09 | -5.89 | -5.86 | -7.46 |
| Average Basic Shares Outstanding | 37.53M | 37.45M | 37.04M | 35.68M | 31.59M |
| Average Diluted Shares Outstanding | 37.53M | 37.45M | 37.04M | 35.68M | 31.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |